Literature DB >> 14530278

Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers.

Emily J Westover1, Douglas F Covey, Howard L Brockman, Rhoderick E Brown, Linda J Pike.   

Abstract

In A431 cells, depletion of cholesterol with methyl-beta-cyclodextrin induced an increase in both basal and epidermal growth factor (EGF)-stimulated EGF receptor phosphorylation. This increase in phosphorylation was site-specific, with significant increases occurring at Tyr845, Tyr992, and Tyr1173, but only minor changes at Tyr1045 and Tyr1068. The elevated level of receptor phosphorylation was associated with an increase in the intrinsic kinase activity of the EGF receptor kinase, possibly as a result of the cyclodextrin-induced enhancement of the phosphorylation of Tyr845, a site in the kinase activation loop known to be phosphorylated by pp60src. Cholesterol and its enantiomer (ent-cholesterol) were used to investigate the molecular basis for the modulation of EGF receptor function by cholesterol. Natural cholesterol (nat-cholesterol) was oxidized substantially more rapidly than ent-cholesterol by cholesterol oxidase, a protein that contains a specific binding site for the sterol. By contrast, the ability of nat- and ent-cholesterol to interact with sphingomyelins and phosphatidylcholine and to induce lipid condensation in a monolayer system was the same. These data suggest that, whereas cholesterol-protein interactions may be sensitive to the absolute configuration of the sterol, sterol-lipid interactions are not. nat- and ent-cholesterol were tested for their ability to physically reconstitute lipid rafts following depletion of cholesterol. nat- and ent-cholesterol reversed to the same extent the enhanced phosphorylation of the EGF receptor that occurred following removal of cholesterol. Furthermore, the enantiomers showed similar abilities to reconstitute lipid rafts in cyclodextrin-treated cells. These data suggest that cholesterol most likely affects EGF receptor function because of its physical effects on membrane properties, not through direct enantioselective interactions with the receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530278      PMCID: PMC2593805          DOI: 10.1074/jbc.M304332200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains.

Authors:  Laura D Zajchowski; Stephen M Robbins
Journal:  Eur J Biochem       Date:  2002-02

2.  Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis.

Authors:  Linda J Pike; Xianlin Han; Koong-Nah Chung; Richard W Gross
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

3.  Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding.

Authors:  Kirstine Roepstorff; Peter Thomsen; Kirsten Sandvig; Bo van Deurs
Journal:  J Biol Chem       Date:  2002-03-08       Impact factor: 5.157

4.  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

Authors:  Hideo Ogiso; Ryuichiro Ishitani; Osamu Nureki; Shuya Fukai; Mari Yamanaka; Jae-Hoon Kim; Kazuki Saito; Ayako Sakamoto; Mio Inoue; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

5.  Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.

Authors:  Thomas P J Garrett; Neil M McKern; Meizhen Lou; Thomas C Elleman; Timothy E Adams; George O Lovrecz; Hong-Jian Zhu; Francesca Walker; Morry J Frenkel; Peter A Hoyne; Robert N Jorissen; Edouard C Nice; Antony W Burgess; Colin W Ward
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

6.  Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking.

Authors:  Linda J Pike; Laurieann Casey
Journal:  Biochemistry       Date:  2002-08-13       Impact factor: 3.162

7.  Lactosylceramide: effect of acyl chain structure on phase behavior and molecular packing.

Authors:  Xin-Min Li; Maureen M Momsen; Howard L Brockman; Rhoderick E Brown
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

8.  Effects of natural and enantiomeric cholesterol on the thermotropic phase behavior and structure of egg sphingomyelin bilayer membranes.

Authors:  David A Mannock; Thomas J McIntosh; Xin Jiang; Douglas F Covey; Ronald N McElhaney
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

9.  Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor.

Authors:  Xu Chen; Marilyn D Resh
Journal:  J Biol Chem       Date:  2002-10-22       Impact factor: 5.157

10.  Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae.

Authors:  Tove Ringerike; Frøydis D Blystad; Finn O Levy; Inger H Madshus; Espen Stang
Journal:  J Cell Sci       Date:  2002-03-15       Impact factor: 5.285

View more
  58 in total

1.  Effect of ring-substituted oxysterols on the phase behavior of dipalmitoylphosphatidylcholine membranes.

Authors:  Md Arif Kamal; V A Raghunathan
Journal:  Eur Biophys J       Date:  2012-06-06       Impact factor: 1.733

2.  Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity.

Authors:  Ikhlas S Ahmed; Hannah J Rohe; Katherine E Twist; Rolf J Craven
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

3.  Slow actions of neuroactive steroids at GABAA receptors.

Authors:  Hong-Jin Shu; Lawrence N Eisenman; Deepani Jinadasa; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

4.  GxxxG motifs, phenylalanine, and cholesterol guide the self-association of transmembrane domains of ErbB2 receptors.

Authors:  Anupam Prakash; Lorant Janosi; Manolis Doxastakis
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

5.  The role of membrane stiffness and actin turnover on the force exerted by DRG lamellipodia.

Authors:  Ladan Amin; Erika Ercolini; Rajesh Shahapure; Elisa Migliorini; Vincent Torre
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

Review 6.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 7.  Lipid raft: A floating island of death or survival.

Authors:  Kimberly S George; Shiyong Wu
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-24       Impact factor: 4.219

8.  ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation.

Authors:  Alexis Stamatikos; Nagadhara Dronadula; Philip Ng; Donna Palmer; Ethan Knight; Bradley K Wacker; Chongren Tang; Francis Kim; David A Dichek
Journal:  Hum Gene Ther       Date:  2018-10-02       Impact factor: 5.695

9.  Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function.

Authors:  Ying Xu; Rob H Henning; Maria Sandovici; Johannes J van der Want; Wiek H van Gilst; Hendrik Buikema
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

10.  Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions.

Authors:  Sarah E Gale; Emily J Westover; Nicole Dudley; Kathiresan Krishnan; Sean Merlin; David E Scherrer; Xianlin Han; Xiuhong Zhai; Howard L Brockman; Rhoderick E Brown; Douglas F Covey; Jean E Schaffer; Paul Schlesinger; Daniel S Ory
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.